Strategies for enhanced radiation delivery in patients with lung cancer Review

Mañon, R, Mehta, M. (2005). Strategies for enhanced radiation delivery in patients with lung cancer . Expert Opinion on Drug Delivery, 2(1), 103-113. 10.1517/17425247.2.1.103

cited authors

  • Mañon, R; Mehta, M

abstract

  • Since the 1970s primary management for regionally advanced non-small cell lung cancer has shifted from radiotherapy alone to sequential chemoradiation to concurrent chemoradiation. The increase in survival with these approaches has been small; an ∼ 3 - 4 month per decade increase in median survival. Future avenues to improve on these outcomes could involve: i) dose-intense radiotherapy; ii) better target delineation; and iii) combining molecularly targeted agents with optimised radiation therapy. However, to accomplish this, techniques to control tumour motion and decrease toxicity must be developed. © 2005 Ashley Publications Ltd.

authors

publication date

  • January 1, 2005

published in

Digital Object Identifier (DOI)

start page

  • 103

end page

  • 113

volume

  • 2

issue

  • 1